13. Demaison L, Moreau D, Vergely-Vandriesse C, Grégoire S, Degois M, Rochette L. Effects of dietary polyunsaturated fatty acids and hepatic
steatosis on the functioning of isolated working rat heart under normoxic conditions and during post-ischemic reperfusion. Mol Cell Biochem 224:
103–116, 2001.
14. Dennis SC, Hearse DJ, Coltart DJ. A model for the generation of sponta-
neous yet predictable ventricular arrhythmias. Eur J Cardiol 12: 377–389, 1981.
15. Díaz R, Paolasso EA, Piegas LS, Tajer CD, Moreno MG, Corvalán R, Isea JE, Romero G. Metabolic modulation of acute myocardial infarc-
tion. The ECLA Estudios Cardiologicos LatinoAmerica Collaborative Group. Circulation 98: 2227–2234, 1998.
16. Dobsak P, Courderot-Masuyer C, Zeller M, Vergely C, Laubriet A, Assem M, Eicher JC, Teyssier JR, Wolf JE, Rochette L. Antioxidative
properties of pyruvate and protection of the ischemic rat heart during cardioplegia. J Cardiovasc Pharmacol 34: 651–659, 1999.
17. Doenst T, Bothe W, Beyersdorf F. Therapy with insulin in cardiac surgery:
controversies and possible solutions. Ann Thorac Surg 75: S721–S728, 2003.
18. Elvenes OP, Korvald C, Irtun O, Larsen T, Sorlie D. Both glucose-
insulin-potassium and glutamine in warm blood cardioplegia increase the rates of myocardial glucose and free fatty acid oxidation. Scand Cardio-
vasc J 36: 19 –26, 2002.
19. Flood A, Hack BD, Headrick JP. Pyruvate-dependent preconditioning
and cardioprotection in murine myocardium. Clin Exp Pharmacol Physiol 30: 145–152, 2003.
20. Forsyth GW, Nagasawa HT, Alexander CS. Ethanol metabolism by the rat
heart and alcohol dehydrogenase activity. Can J Biochem 54: 539 –545, 1976.
21. Gao F, Shi DW, Wang XM, Dong L, Wang YM, Ma XL. Effects of
glucose-insulin-potassium cocktail on cardiac myocyte death and post- ischemic recovery cardiac functional recovery: the critical role of insulin.
Zhonghua Nei Ke Za Zhi 42: 148 –152, 2003.
22. Griffin JL, White LT, Lewandowski ED. Substrate-dependent proton
load and recovery of stunned hearts during pyruvate dehydrogenase stimulation. Am J Physiol Heart Circ Physiol 279: H361–H367, 2000.
23. Goodwin GW, Taegtmeyer H. Metabolic recovery of isolated working
rat heart after brief global ischemia. Am J Physiol Heart Circ Physiol 267: H462–H470, 1994.
24. Gralinski MR, Black SC, Kilgore KS, Chou AY, Mccormack JG, Lucchesi BR. Cardioprotective effects of ranolazine RS-43285 in the
isolated perfused rabbit heart. Cardiovasc Res 28: 1231–1237, 1994.
25. Gutterman DD, Chilian WM, Eastham CL, Inou T, White CW, Marcus ML. Failure of pyruvate to salvage myocardium after prolonged
ischemia. Am J Physiol Heart Circ Physiol 250: H114 –H120, 1986.
26. Hachida M, Ookado A, Nonoyama M, Koyanagi H. Effect of HTK
solution for myocardial preservation. J Cardiovasc Surg Torino 37: 269 –274, 1996.
27. Hess ML, Okabe E, Poland J, Warner M, Stewart JR, Greenfield LJ.
Glucose, insulin, potassium protection during the course of hypothermic global ischemia and reperfusion: a new proposed mechanism by the
scavenging of free radicals. J Cardiovasc Pharmacol 5: 35–43, 1983.
28. Jonassen AK, Brar BK, Mjos OD, Sack MN, Latchman DS, Yellon DM. Insulin administered at reoxygenation exerts a cardioprotective effect
in myocytes by a possible anti-apoptotic mechanism. J Mol Cell Cardiol 32: 757–764, 2000.
29. Jonassen AK, Aasum E, Riemersma RA, Mjos OD, Larsen TS.
Glucose-insulin-potassium reduces infarct size when administered during reperfusion. Cardiovasc Drugs Ther 14: 615–623, 2000.
30. Johnston DL, Lewandowski ED. Fatty acid metabolism and contractile
function in the reperfused myocardium. Multinuclear NMR studies of isolated rabbit hearts. Circ Res 68: 714 –725, 1991.
31. Kobayashi K, Neely JR. Mechanism of pyruvate dehydrogenase activa-
tion by increased cardiac work. J Mol Cell Cardiol 15: 369 –382, 1983.
32. Korb H, Hoeft A, Hunneman DH, Schraeder R, Wolpers HG, Wober W, Hellige G. Changes in myocardial substrate utilisation and protection
of ischemic stressed myocardium by oxfenicine [S-4-hydroxyphenylg- lycine]. Naunyn Schmiedebergs Arch Pharmacol 327: 70 –74, 1984.
33. Korvald C, Elvenes OP, Myrmel T. Myocardial substrate metabolism
influences left ventricular energetics in vivo. Am J Physiol Heart Circ Physiol
278: H1345–H1351, 2000.
34. Ladisa JF, Krolikowski JG, Pagel PS, Warltier DC, Kersten JR.
Cardioprotection by glucose-insulin-potassium: dependence on K-ATP channel opening and blood glucose concentration before ischemia. Am J
Physiol Heart Circ Physiol 287: H601–H607, 2004.
35. Langendorff O. Untersuchungen am überlebenden Saügetierherzen.
Pflügers Arch 61: 291–332, 1895.
36. Lazar HL, Zhang X, Rivers S, Bernard S, Shemin RJ. Limiting
ischemic myocardial damage using glucose-insulin-potassium solutions. Ann Thorac Surg
60: 411–416, 1995.
37. Lazar HL. Enhanced preservation of acutely ischemic myocardium and
improved clinical outcomes using glucose-insulin-potassium GIK solu- tions. Am J Cardiol 80: 90A–93A, 1997.
38. Longnus SL, Wambolt RB, Barr RL, Lopaschuk GD, Allard MF.
Regulation of myocardial fatty acid oxidation by substrate supply. Am J Physiol Heart Circ Physiol
281: H1561–H1567, 2001.
39. Lopaschuk GD, McNeil GF, McVeigh JJ. Glucose oxidation is stimu-
lated in reperfused ischemic hearts with the carnitine palmitoyltransferase 1 inhibitor, etomoxir. Mol Cell Biochem 88: 175–179, 1989.
40. Lopaschuk GD, Barr R, Thomas PD, Dyck JR. Beneficial effects of
trimetazidine in ex vivo working ischemic hearts are due to a stimulation of glucose oxidation secondary to inhibition of long-chain 3-ketoacyl
coenzyme A thiolase. Circ Res 93: 33–37, 2003.
41. Marzilli M. Management of ischaemic heart disease in diabetic patients. Is
there a role for cardiac metabolic agents? Curr Med Res Opin 17: 153–158, 2001.
42. McCormack JG, Barr RL, Wolff AA, Lopaschuk GD. Ranolazine
stimulates glucose oxidation in normoxic, ischemic, and reperfused isch- emic rat hearts. Circulation 93: 135–142, 1996.
43. Nuutinen EM. Subcellular origin of the surface fluorescence of reduced
nicotinamide nucleotides in the isolated perfused rat heart. Basic Res Cardiol
79: 49 –58, 1984.
44. Pache J, Kastrati A, Mehilli J, Bollwein H, Ndrepepa G, Schuhlen H, Martinoff S, Seyfarth M, Nekolla S, Dirschinger J, Schwaiger M,
Schömig A. A randomized evaluation of the effects of glucose-insulin- potassium infusion on myocardial salvage in patients with acute myocar-
dial infarction treated with reperfusion therapy. Am Heart J 148: e3, 2004.
45. Peckova M, Fahrenbruch CE, Cobb LA, Hallstrom AP. Circadian
